๐ข Recruiting
Phase 3
๐ Investigational Drug / Biologic
NCT06744920
A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis
๐ Neuromuscular Research Center โ Phoenix, Arizona
View Study & Checklist โ